🛡️ CVE-2022-35488 — zammad

🟠 CVSS 7.5 — High ✅ No Known Exploit NVD
7.5
CVSS Score
0 Low4 Medium7 High9 Critical10

Description

In Zammad 5.2.0, an attacker could manipulate the rate limiting in the 'forgot password' feature of Zammad, and thereby send many requests for a known account to cause Denial Of Service by many generated emails which would also spam the victim.

How this vulnerability can be exploited

This issue can be reached over the network, attack complexity is low, an attacker needs no privileges on the target. No user interaction is required. The scope is unchanged, so the impact stays within the vulnerable component. Rated impact: confidentiality none, integrity none, availability high.

Affected software

CVE-2022-35488 is recorded against 1 package.

  • zammad

Timeline and source

Published on 8 August 2022 and last revised on 17 June 2026. No public exploit is currently recorded for this entry. Record sourced from NVD.

References

zammad.com
zammad.com

Details

Severity HIGH
CVSS Score 7.5
CVSS Vector CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H
CWE N/A
Public Exploit ✅ No
Source NVD
Published 2022-08-08
Updated 2026-08-11
Modified 2026-06-17
Fix URL N/A

Affected Packages

Software From version Fixed in
zammad

Similar Threats

Site Security Check

Is zammad part of your stack?

CVE-2022-35488 is rated CVSS 7.5 High. BotEraser scans your installation against known CVE records and tells you whether this vulnerability applies to the versions you actually run.

Scan My Site Free →

No credit card required  ·  Results in minutes

ⓘ Data Notice: The information presented above has been compiled from publicly available internet sources. Boteraser aggregates this data solely for informational purposes and does not independently classify, evaluate, or endorse any findings about the vulnerabilities listed. The accuracy and completeness of this information is the sole responsibility of the original publishers. Boteraser and its operators accept no liability for any decisions made based on this data.

Browse related advisories

All advisoriesCVECVE 2022